Abstract 3719: Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: Clinical and pharmacogenetic results
Keyword(s):
Phase Ii
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4126-4126
2010 ◽
Vol 28
(15_suppl)
◽
pp. 4142-4142